Ligustrum robustum Intake, Weight Loss, and Gut Microbiota: An Intervention Trial

Table 2

Characters of the study participants at baseline and 12 wk.

Characters	Baseline	4 wk	12 wk	P
Weight, kg	70.27±8.75	69.82±8.69	68.50±8.44	<.01
BMI, kg/m^2	29.85±3.70	29.67±3.73	29.09±3.54	<.01
Fat, kg	29.35±6.84	28.64±7.00	27.24±7.12	<.01
Fat, %	41.33±5.27	40.53±5.74	39.25±6.37	<.01
Protein, kg	8.04±0.70	8.12±0.69	8.08±0.73	0.46
Muscle, kg	22.23±2.11	22.49±2.11	22.40±2.19	0.41
Viscera fat area, cm^2	107.65, 32.50	105.20, 37.10	102.40, 28.20	<.01
Fitness score	67.00, 8.00	67.00, 7.00	68.00, 8.00	0.03
Abdomen Circumference, cm	95.43±8.19	95.56±8.67	92.26±8.78	<.01
Hip Circumference, cm	100.88±5.51	100.76±5.47	100.28±5.53	0.45
Metabolic rate, kcal/d	1253.74±76.90	1259.46±76.80	1261.04±82.03	0.59
Physical activity, MET-h/wk	140.88, 162.75	65.13, 70.75	67.90, 0.6.67	0.01
Dietary intake per day
Energy, kcal	1998.23±529.47	NA	1920.45±611.10	0.62
Protein, g	68.88±20.03	NA	65.67±17.18	0.55
Fat, g	79.56±38.06	NA	69.65±24.57	0.85
Carbohydrate, g	257.36±70.12	NA	261.81±108.78	0.27

Data with normal distribution are presented as mean ± SD and data with nonnormal distribution are presented as median, interquartile range.
P values were calculated by paired T test for normal distribution variables and Wilcoxon signed-rank test for nonparametric tests. We used linear models and Friedman’s test to analyze repeated measurement at baseline and 4 and 12 weeks when needed.
P<0.05.